Characterization of age- and dose-related outcomes of duck hepatitis B virus infection

Virology

Volumn 244, Issue 2, 1998, Pages 273-282

  Jilbert, Allison R ^a,b   Botten, James A ^b   Miller, Darren S ^b   Bertram, Edward M ^b   Hall, Pauline De La M ^c   Kotlarski, Ieva ^b   Burrell, Christopher J ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DUCK; HEPATITIS B VIRUS; IMMUNE RESPONSE; INOCULATION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIREMIA; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

ANAS; ANAS SP.; ANIMALIA; DNA VIRUSES; DUCK HEPATITIS B VIRUS; HEPATITIS B VIRUS;

EID: 17344379240     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9095     Document Type: Article

References (38)

1. Barker L. F., Murray R. Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis-associated antigen. Am. J. Med. Sci. 263:1972;27-33.
2. Barrios C., Brawand P., Berney M., Brandt C., Lambert P. H., Siegrist C. A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: Predominance of a Th2-biased pattern that persists after adult boosting. Eur. J. Immunol. 26:1996;1489-1496.
3. Barthold S. W., Beck D. S., Smith A. L. Enterotropic coronavirus (mouse hepatitis virus) in mice: Influence of host age and strain on infection and disease. Lab. Anim. Sci. 43:1993;276-284.
4. Bertram E. M., Wilkinson R. G., Lee B. A., Jilbert A. R., Kotlarski I. Identification of duck T lymphocytes using an anti-human T cell (CD3) antiserum. Vet. Immunol. Immunopathol. 51:1996;353-363.
5. Bertram E. M., Jilbert A. R., Kotlarski I. An homologousin vitro. Vet. Immunol. Immunopathol. 56:1997a;163-174.
6. Bertram E. M., Jilbert A. R., Kotlarski I. Optimisation of anin vitro. Dev. Comp. Immunol. 21:1997b;299-310.
7. Bertram E. M. Characterisation of Duck Lymphoid Cell Populations and Their Role in Immunity to Duck Hepatitis B Virus. 1997;University of Adelaide.
8. Carp N. Z., Saputelli J., Halbherr T. C., Mason W. S., Jilbert A. R. A technique for liver biopsy performed in Pekin ducks utilising anaesthesia with Telazol. Lab. Anim. Sci. 41:1991;474-475.
9. Chisari F. V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:1995;29-60.
10. Cullen J. M., Marion P. L., Newbold J. E. A sequential histologic and immunohistochemical study of duck hepatitis B virus infection in Pekin ducks. Vet. Pathol. 26:1989;164-172.
11. Forsthuber T., Yip H. C., Lehmann P. V. Induction of TH1 and TH2 immunity in neonatal mice. Science. 271:1996;1728-1730.
12. Fukuda R., Fukumoto S., Shimada Y. A sequential study of viral DNA in serum in experimental transmission of duck hepatitis B virus. J. Med. Virol. 21:1987;311-320.
13. Gerin J. L. Experimental WHV infection of woodchucks: An animal model of hepadnavirus-induced liver cancer. Gastroenterol. Jpn. Suppl. 2:1990;38-42.
14. Greenlee J. E. Effect of host age on experimental K virus infection in mice. Infect. Immun. 33:1981;297-303.
15. Griffin D. E., Levine B., Tyor W. R., Tucker P. C., Hardwick J. M. Age-dependent susceptibility to fatal encephalitis: alphavirus infection of neurons. Arch. Virol. Suppl. 9:1994;31-39.
16. Guidotti L. G., Ishikawa T., Hobbs M. V., Matzke B., Schreiber R., Chisari F. V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:1996;25-36.
17. Jilbert A. R., Freiman J. S., Burrell C. J., Holmes M., Gowans E. J., Rowland R., Hall P., Cossart Y. E. Virus-liver cell interactions in duck hepatitis B virus infection: A study of virus dissemination within the liver. Gastroenterology. 95:1988;1372-1382.
18. Jilbert A. R., Wu T-T., England J. M., Hall P. M., Carp N. Z., O'Connell A. P., Mason W. S. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J. Virol. 66:1992;1377-1388.
19. Jilbert A. R., Miller D. S., Scougall C. A., Turnbull H., Burrell C. J. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: One virus DNA genome is infectious in neonatal ducks. Virology. 226:1996;338-345.
20. Jubelt B., Narayan O., Johnson R. T. Pathogenesis of human poliovirus infection in mice. II. Age dependency of paralysis. J. Neuropathol. Exp. Neurol. 39:1980;149-159.
21. Kajino K., Jilbert A. R., Saputelli J., Aldrich C. E., Cullen J., Mason W. S. Woodchuck hepatitis virus infections: Very rapid recovery after prolonged viremia and infection of virtually every hepatocyte. J. Virol. 68:1994;5792-5803.
22. Kintner R. L., Brandt C. R. The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection. Curr. Eye Res. 14:1995;145-152.
23. Lok A. S. Natural history and control of perinatally acquired hepatitis B virus infection. Dig. Dis. 10:1992;46-52.
24. Marion P. L., Knight S. S., Ho B. K., Guo Y. Y., Robinson W. S., Popper H. Liver disease associated with duck hepatitis B virus infection. Proc. Natl. Acad. Sci. USA. 81:1984;898-902.
25. Marion P. L., Cullen J. M., Azcarraga R. R., Van-Davelaar M. J., Robinson W. S. Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese. Hepatology. 7:1987;724-731.
26. Montgomery R. D., Villegas P., Kleven S. H. Role of route of exposure, age, sex, and type of chicken on the pathogenicity of avian reovirus strain 81-176. Avian Dis. 30:1986;460-467.
27. Nickel R., Schummer A., Seiferle E. Anatomy of the Domestic Birds. 1977;Parey, Berlin.
28. Pugh J. C., Yaginuma K., Koike K., Summers J. Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectiousin vitro. J. Virol. 62:1988;3513-3516.
29. Pugh J. C., Di Q., Mason W. S., Simmons H. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles. J. Virol. 69:1995;4814-4822.
30. Qiao M., Gowans E. J., Bailey S. E., Jilbert A. R., Burrell C. J. Serological analysis of duck hepatitis B virus infection. Virus Res. 17:1990;3-4.
31. Ramig R. F. The effects of host age, virus dose, and virus strain on heterologous Rotavirus infection of suckling mice. Microb. Pathog. 4:1988;189-202.
32. Ridge J. P., Fuchs E. J., Matzinger P. Neonatal tolerance revisited: Turning on newborn cells with dendritic cells. Science. 271:1996;1723-1726.
33. Roessler D. E., Rosenberger J. K. In vitroin vivo. Avian Dis. 33:1989;555-565.
34. Sarzotti M., Robbins D. S., Hoffman P. M. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science. 271:1996;1726-1728.
35. Steiner C. M., Rozhon E. J., Lipton H. L. Relationship between host age and persistence of Theiler's virus in the central nervous system of mice. Infect. Immun. 43:1984;432-434.
36. Tagawa M., Omata M., Yokosuka O., Uchiumi K., Imazeki F., Okuda K. Early events in duck hepatitis B virus infection: Sequential appearance of viral deoxyribonucleic acid in the liver, pancreas, kidney, and spleen. Gastroenterology. 89:1985;1224-1229.
37. Vickery K., Cossart Y. E. DHBV manipulation and prediction of the outcome of infection. J. Hepatol. 25:1996;504-509.
38. Zinkernagel R. M. Immunology taught by viruses. Science. 271:1996;173-178.